Adanma Ayanambakkam
University of Oklahoma
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adanma Ayanambakkam as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07223541 · Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell CarcinomaUniversity of Oklahoma · recruiting · Clear Cell Renal Cell Carcinoma · principal investigator
- Ph2NCT07183319 · Circulating Tumor DNA Response In Urothelial CancerUniversity of Oklahoma · recruiting · Urothelial Carcinoma · principal investigator
- N/ANCT06960798 · Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)University of Oklahoma · recruiting · Prostate Cancer, Renal Cell Carcinoma (RCC) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.